Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
16.71
+0.22 (1.33%)
Jun 8, 2026, 11:22 AM EDT - Market open
Caris Life Sciences Revenue
Caris Life Sciences had revenue of $216.17M in the quarter ending March 31, 2026, with 78.78% growth. This brings the company's revenue in the last twelve months to $907.29M, up 100.51% year-over-year. In the year 2025, Caris Life Sciences had annual revenue of $812.03M with 96.97% growth.
Revenue (ttm)
$907.29M
Revenue Growth
+100.51%
P/S Ratio
5.30
Revenue / Employee
$491,491
Employees
1,846
Market Cap
4.72B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 812.03M | 399.77M | 96.97% |
| Dec 31, 2024 | 412.26M | 106.13M | 34.67% |
| Dec 31, 2023 | 306.13M | 47.64M | 18.43% |
| Dec 31, 2022 | 258.49M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCAI News
- 2 hours ago - Caris Life Sciences announces $100M share repurchase program - TheFly
- 4 days ago - Caris Life Sciences Transcript: AGM 2026 - Transcripts
- 6 days ago - Caris Life Sciences assumed with a Peer Perform at Wolfe Research - TheFly
- 6 days ago - Caris Life Sciences assumed at Peer Perform from Outperform at Wolfe Research - TheFly
- 26 days ago - Caris Life Sciences Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 27 days ago - Caris Life Sciences announces publication of study on measuring TMB using WES - TheFly
- 4 weeks ago - Caris Life Sciences submits application to NYSDOH for Caris Assure testing - TheFly
- 4 weeks ago - Caris Life Sciences price target lowered to $22 from $28 at Baird - TheFly